Context and objectives of the recommendation

Back to decision-making tree Print last updated on 21/02/2024

Objective

The objective of this work has been to provide an update on the drug and non-drug treatments of chronic spontaneous urticaria (CSU) in adults and children, based on data from the literature reviewed by a working group with no conflicts of interest with respect to the pharmaceutical industry and pharmacovigilance.

The physician will thus be able to use this data to help make decisions for each patient.

Medical professionals concerned

Prescribing physicians such as dermatologists, allergists, general practitioners, paediatricians and internists.

Working group

A multidisciplinary working group (WG) was set up at the request of the presidents of the various French scientific societies working in disciplines traditionally involving the care of patients with CSU.

Its members were:

• President:
  Annabel MARUANI (University professor and hospital practitioner, university and hospital dermatology) — Tours
• Paediatricians in private practice:
  Gwenaelle D’ACREMONT — Paris 9^th district
• Methodology, university and hospital biostatistics:
  Bruno GIRAUDEAU — Tours
• Hospital allergology and dermatology:
  Florence HACARD — Lyon
• Private-practice dermatology:
  Marie-Hélène JEGOU — Blanquefort
• Hospital pharmacology:
  Annie-Pierre JONVILLE-BERA — Tours
• University and private general practitioners:
  Stéphane MUNCK — Nice
• University and hospital immunology:
  Bach-Nga PHAM — Reims

➜